Dr. David J Dubois, D.D.S Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 179 Hospital Dr, Spruce Pine, NC 28777 Phone: 828-765-0110 |
Dr. Taylor Franklin Townsend, D.D.S. Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 54 Broad St, Spruce Pine, NC 28777 Phone: 828-765-7383 Fax: 828-765-5293 |
Dr. John Ralph Royal, DDS Dentist Medicare: Medicare Enrolled Practice Location: 179 Hospital Dr, Spruce Pine, NC 28777 Phone: 719-955-4023 Fax: 719-955-4046 |
Dr. Julius R Aldridgeg, DDS Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 342 Oak Ave, Spruce Pine, NC 28777 Phone: 828-765-8125 Fax: 828-765-2988 |
Dr. Bruce Dennis Crawford, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 600 Amity Park Rd, Dental-avery Mitchell Correctional Institution, Spruce Pine, NC 28777 Phone: 828-765-0229 Fax: 828-766-7015 |
Amber Shaikh, DDS Dentist Medicare: Medicare Enrolled Practice Location: 179 Hospital Dr, Spruce Pine, NC 28777 Phone: 828-765-0110 |
Dr. Barbara L. Bressert, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 54 Broad St, Spruce Pine, NC 28777 Phone: 828-765-7383 Fax: 828-765-5293 |
News Archive
Microdosing of psychedelic substances involves taking very small doses of a psychedelic drug such as LSD or psilocybin (magic mushrooms) over weeks or even months. There have been anecdotal claims that such microdosing can improve health and also performance and relationships. These earlier studies dealt with the one time effect of microdosing.
People with moderate to severe malaria who are too ill to take oral medication can benefit from a single dose of rectal artesunate as initial treatment, conclude authors of a study in this week's issue of THE LANCET.
Alzheimer's Research UK is calling for urgent investment in dementia research, following new statistics that show the condition accounted for 13% of all UK deaths last year. The figures were released by the Office for National Statistics today (Wednesday 18 July).
The Healthcare Group Purchasing Industry Initiative, an organization dedicated to promoting the highest ethical standards and practices in the health care group purchasing industry, today announced the launch of two major initiatives to further increase transparency and strengthen oversight in the health care group purchasing industry.
Maxygen, Inc., a biotechnology company focused on the development of improved protein drugs, today announced that its option and licensing arrangement with Cangene Corporation has expired. Under the agreement, Maxygen had granted Cangene an option to obtain an exclusive license to Maxygen's proprietary MAXY-G34 protein therapeutic for use in treating acute radiation syndrome.
› Verified 6 days ago